Wiesmueller, F.; Kopke, J.; Aust, D.; Roy, J.; Dahl, A.; Pilarsky, C.; Grützmann, R.
Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer. Int. J. Mol. Sci. 2019, 20, 5437.
https://doi.org/10.3390/ijms20215437
AMA Style
Wiesmueller F, Kopke J, Aust D, Roy J, Dahl A, Pilarsky C, Grützmann R.
Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer. International Journal of Molecular Sciences. 2019; 20(21):5437.
https://doi.org/10.3390/ijms20215437
Chicago/Turabian Style
Wiesmueller, Felix, Josephin Kopke, Daniela Aust, Janine Roy, Andreas Dahl, Christian Pilarsky, and Robert Grützmann.
2019. "Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer" International Journal of Molecular Sciences 20, no. 21: 5437.
https://doi.org/10.3390/ijms20215437
APA Style
Wiesmueller, F., Kopke, J., Aust, D., Roy, J., Dahl, A., Pilarsky, C., & Grützmann, R.
(2019). Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer. International Journal of Molecular Sciences, 20(21), 5437.
https://doi.org/10.3390/ijms20215437